TLR4 and colitis: In vitro, soyasaponin Ab administration to TLR4 siRNA-treated peritoneal macrophages did not affect TLR4 expression or LPS-induced NF-κB activation, suggesting that soyasaponin may ameliorate colitis through the inhibition of LPS binding to TLR4 on macrophages [42].